Multiple sclerosis (MS) and its animal model, myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (MOG-EAE), share a complex genetic predisposition with contributions from the major histocompatibility complex class II genes and many other genes. Linkage mapping in F 2 crosses between the susceptible DA rat strain and the resistant ACI or BN rat strains in various models of autoimmune neuroinflammation have repeatedly displayed suggestive linkage to a region on rat chromosome 15. A direct study of this region was undertaken in congenic strains by transferring resistant ACI alleles to the susceptible DA background. Phenotypic analysis demonstrated lower maximal and cumulative EAE scores in the DA.ACI-D15Rat6-D15Rat71 (C15), DA.ACI-D15Rat6-D15Rat48, D15Rat126-D15Rat71 (C15R3b), and DA.ACI-D15Rat23-D15rat71 (C15R4) strains compared to the parental DA rat strain. Linkage analysis was then performed in a (DA ϫ PVG.AV1)F 7 advanced intercross line, resulting in a LOD score of 4.7 for the maximal EAE score phenotype at the peak marker D15Rat71 and a confidence interval of 13 Mb, overlapping with the congenic fragment defined by the C15R3b and the C15R4 strains. Thus, a new MOG-EAE locus with the designation Eae19 is identified on rat chromosome 15. There are 32 confirmed or predicted genes in the confidence interval, including immune-responsive gene 1 and neuronal ceroid lipofuscinose gene 5. Definition of loci such as Eae19 enables the characterization of genetically regulated, evolutionary conserved disease pathways in complex neuroinflammatory diseases.
M ULTIPLE sclerosis (MS) is a chronic inflamma-
genes represent evolutionarily conserved disease pathtory demyelinating disease that affects the central ways that are prime candidates for therapeutic intervennervous system. Susceptibility to MS is based on interactions. A major problem for other approaches in MS, tions among several genes and influences by, largely such as studying selected candidate regulatory moleunknown, nongenetic factors (Ebers et al. 1986 (Ebers et al. , 1995  cules and cellular subsets, is to determine if the observed Sadovnick et al. 1993 Sadovnick et al. , 1996 Ebers 1996) . The major deviation is a cause or consequence of disease and if the histocompatibility complex (MHC) has been known to pathway is involved in disease progression or protection. regulate MS since 1972 (Jersild et al. 1973 ; Ebers et EAE induced with myelin oligodendrocyte glycoproal. 1986; Olerup and Hillert 1991) . So far, very few tein (MOG) in certain rat strains shares features of MS individual non-MHC genes regulating MS have been such as a relapsing/remitting disease course and a identified by whole-genome scans or association studies prominent demyelination (Adelmann et al. 1995 ; Johns due to the heterogeneity, polygeneity, and environmenet al. 1995) . The formation of demyelinated lesions in tal influences in MS (Ebers et al. 1996 ; Haines et al. MOG anti-1996 MOG anti- , 2002 Sawcer et al. 1996; Kuokkanen et al. 1997;  bodies (Linington et al. 1988) . MHC class II genes and Chataway et al. 1998; Broadley 2001; Coraddu 2001;  multiple other genes influence this response (Weissert Akesson et al. 2002; Ban et al. 2002) . Animal models of et al. 1998b; Dahlman et al. 1999b; Jagodic et al. 2001) . MS, such as experimental autoimmune encephalomyeliAn autoimmune response against MOG in MS patients tis (EAE), can circumvent these problems by minimizing suggests that MOG plays an important role also in the the heterogeneity and controlling the environmental pathogenesis of MS (Sun et al. 1991; De Rosbo et al. conditions (Lucchinetti et al. 1996; Lassmann et al. 1993; Wallstrom et al. 1998) . Thus, MOG-EAE is a 2001). Unbiased identification of genes controlling aurelevant model to utilize in studies of mechanisms untoimmune neuroinflammation is important, since such derlying the development of autoimmune neuroinflammation. The dark Agouti (DA) rat strain is susceptible to MOG-EAE, while the PVG.AV1 and the ACI strains 1 performed and heterozygous rats for the chromosome 15 retype RT1.AV1 (Hedrich 1990 MOG-EAE and EAN, the suggestive linkage was ob-(C15R4) for experiments. After the fifth experiment we regenoserved in (DA ϫ ACI)F 2 rats subjected to genome scans typed the rats and found that some C15R3 rats shared a region with microsatellite markers (Dahlman et al. 1999b (Dahlman et al. , 2001 ).
MOG-EAE depends on both T cells and anti-
with the C15R4 from D15Rat126 to D15Rat71, so we separated the C15R3 into DA.ACI-D15Rat6-D15Rat48 (C15R3a) and
In spinal-cord-induced EAE, a suggestive linkage was DA.ACI-D15Rat6-D15rat48, D15Rat126-D15Rat71 (C15R3b) acobserved in (DA ϫ BN)F 2 rats (Dahlman et al. 1999a ).
cording to the genotyping results.
To determine if the rat chromosome 15 region indeed EAE experiments.
Induction and clinical assessment of MOG-EAE:
The rats were anesthetized with sevoflurane and immunized intrader-MATERIALS AND METHODS mally in the tail base. Each rat received 200-l inoculums containing 100 l recombinant rat MOG (rMOG; aa 1-125) Parental rat strains and basic conditions: DA rats were origiin saline emulsified in 100 l incomplete Freund's adjuvans nally obtained from the Zentralinstitut for Versuchstierzucht (Sigma-Aldrich, St. Louis). The dose of rMOG (aa 1-125) was (Hans Hedrich, Hannover, Germany) and A ϫ C 9935 Irish selected upon titration in the susceptible parental DA rats. In (ACI) rats were from Harlan Sprague Dawley (Indianapolis).
the congenic strain experiments, the dose was 13, 20, or 65 MHC-congenic (RT1.AV1) Piebald-Viral-Glaxo (PVG) rats, g/rat, depending on the batch of rMOG, and 40 g/rat for PVG.AV1 (also previously referred to as PVG-RT1 a ), were obthe AIL animals. Animals were weighed and clinical signs of tained from Harlan UK (Blackthorn, UK). All the rats were disease were evaluated from day 7 to day 33-40 postimmunizalocally bred in the animal facility at the Center for Molecular tion (p.i.). The clinical signs were scored as follows: 1, tail Medicine, Karolinska Institutet. Eight-to 15-week-old male weakness or tail paralysis; 2, hind leg paraparesis (gait disturand female rats were used in the six experiments with congenic bance) or hemiparesis; 3, hind leg paraparalysis or hemipararats. Rats were routinely tested for specific pathogens aclysis; 4, tetraparalysis, urinary, and/or fecal incontinence. A cording to a health-monitoring program for rats at the Narelapsing/remitting disease course was defined as an improvetional Veterinary Institute in Uppsala, Sweden. They were kept ment in the disease score either from 3 or 4 to 1 or from 2, in a 12-hr light/12-hr dark cycle and housed in polystyrene 3, or 4 to 0, which was maintained for at least 2 consecutive cages containing aspen wood shavings, with free access to days and followed by an increase in the clinical score of at water and autoclaved standard rodent chow. The local ethical least 2 points that lasted for at least 2 days. committee approved the experiments.
Genotyping: A total of 152 clinically affected rats and 162 Breeding of the chromosome 15 congenic strains and the randomly selected unaffected rats in the (DA ϫ PVG.AV1)F 7 advanced intercross line: Speed congenics were generated with AIL were genotyped. Affected animals were selected on the a marker-assisted selection technique, mainly as described by basis of displaying unambiguous signs of the disease (mini- Wakeland et al. (1997) . An ‫-52ف‬cM fragment of ACI alleles mum score 1 for Ͼ2 days accompanied with weight loss). Rats from the D15Rat6 marker to the D15Rat71 marker was transin the unaffected group did not display any signs of disease, ferred to the DA rat background. Initially, (DA ϫ ACI)F 1 rats including a steady increase in weight ( Jagodic et al. 2004) . were backcrossed to DA rats. From the N 2 generation, the rats DNA was extracted from the tail tip according to a standard were genotyped with 70 microsatellite markers outside the protocol (Laird et al. 1991) . The region analyzed in the AIL congenic region, with a mean distance between markers of included the region defined in the full-length congenic C15 20 cM. One male rat from each generation, having the least strain ( Figure 1 ). This 25-cM ‫35ف(‬ Mb) large region, examount of remaining donor (ACI) alleles in the genome, tending from D15Rat6 to D15Rat71, was first genotyped with was selected for further breeding and mated with several DA 15 microsatellite markers, and then another region from female rats. In the N 6 generation, all 70 background markers were fixed as DA homozygous. One further backcross was D15Rat71 to D15Rat103 ‫51ف(‬ Mb) near the telomere was Eae19, a New Locus on Rat Chromosome 15 Figure  ( n ϭ 72), C15 (n ϭ 49), C15R1 (n ϭ 23), C15R3a (n ϭ 9), 4). The microsatellite markers were obtained from Proligo C15R3b (n ϭ 14), and C15R4 (n ϭ 17) strains. Maximum France SAS (Paris). Polymerase chain reaction (PCR) amplifi-EAE score, cumulative EAE score, and onset day were tested cation was performed as previously described with [␥-33 P]ATP with the Wilcoxon two-sample test after normalization; *P Ͻ end labeling of the forward primer ( Jacob et al. 1995) . The 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001. Pairwise comparisons PCR products were size fractionated on 6% polyacrylamide were made with the congenic strains and the DA strain. Mean gels and visualized by autoradiography. All genotypes were values and SEM for disease onset day after immunization were evaluated manually and double checked. calculated only for affected rats. Statistical analysis: Differences in binominal traits (incidence, relapsing/remitting disease, mortality) were tested with the Fisher's exact test. Differences in the maximal score, the cumulative scores, and onset day were tested with the Wilcoxon two-sample test after normalization of the six sepagenerated with 5000 permutations were 2.3 for the incidence rate experiments. Normalization was performed by subtracting of EAE, 2.0 for the day of onset, 2.9 for the maximum EAE the mean maximal or cumulative EAE score for the particular score, and 2.2 for the cumulative EAE score. The confidence experiment from each individual rat's corresponding score interval was defined as a drop of 1 in the LOD score (Lander and then the sum was divided with the standard deviation for and Botstein 1989). the particular experiment. This allowed all experiments to be analyzed together, despite the variation in the severity of disease in the parental DA rat strain. The JMP 5.1 software (SAS RESULTS Institute, Cary, NC) was utilized for the analysis above. Linkage analysis in the AIL was performed with the R/qtl software A reduced MOG-EAE severity in the C15, C15R3b, (Broman et al. 2003) . Permutation tests in the R/qtl software and C15R4 strains: Figure 2 gives the mean maximal were used to determine the significance levels (Churchill and Doerge 1994). The LOD levels for significant linkage cumulative score and onset day of the EAE in DA rats Experiment 5: a severe disease in DA rats (n ϭ 16) and reduced disease severity in C15R3b (n ϭ 5) and C15R4 (n ϭ 9) rats. and in congenic C15 and recombinant congenic C15R1, PVG.AV1)F 7 rats were monitored 31 days p.i. for clinical signs of EAE. Unambiguous signs of EAE were recorded C15R3a, C15R3b, and C15R4 rats pooled from six separate experiments after the normalization. DA, C15R1, in 14.8% (158/1068) of the rats. A detailed account of the EAE disease outcome in the F 7 (DA ϫ PVG.AV1) and C15R3a rats developed EAE with a high maximal and cumulative EAE score while the C15, C15R3b, and AIL rats has been published ( Jagodic et al. 2004 ). All available EAE-affected rats were selected for genotyping C15R4 rats had less severe MOG-EAE, with lower maximal and cumulative EAE scores (P Ͻ 0.05-0.001); C15R3b rats (n ϭ 152). Randomly selected healthy rats, displaying no signs of EAE and no weight loss, were genotyped in had late onset of disease compared to DA rats (P Ͻ 0.05). The disease incidence, the numbers of rats disparallel (n ϭ 162). The DA ϫ PVG.AV1 strain combination provided a substantially higher degree of polymorplaying a relapsing/remitting disease, or a lethal EAE were not significantly different in any of the congenic phic microsatellite markers than the DA ϫ ACI combination did, as expected. Linkage analysis resolved the C15 strains compared to the DA strain (data not shown). However, the power of this analysis was reduced due to region into a significant locus, named Eae19 (http:/ /ratmap. org/), displaying linkage to several EAE phenotypes. the variable expression of EAE in the DA strain, as depicted in Figure 3 . In experiment 3 (Figure 3a) , there Interestingly, the disease incidence and the day of onset was linked to Eae19, indicating that the EAE regulatory were only mild signs of disease in the DA rats and almost no disease signs in the C15 rats. The disease signs in effect is not limited to the disease severity, as suggested by the analysis of the congenic strains. The LOD score the DA rats were much more severe in experiment 5, while the R3b and R4 displayed a reduced disease severcurves for the different EAE phenotypes are presented in Figure 4 . The confidence interval, defined as a drop ity (Figure 3b ). The overall disease severity was intermediate in experiment 1, mild in experiment 2, and severe of 1 in the LOD score, comprises an ‫-31ف‬Mb region (D15Mgh4-D15Rat102). The DA allele at the peak in experiments 4 and 6 (data not shown).
Eae19 delineated by linkage mapping in a (DA ϫ marker (D15Rat71) is disease enhancing in an additive fashion. Sequence alignments and map comparisons PVG.AV1) AIL: A total of 1068 MOG-immunized (DA ϫ of several genes and/or genes that differ between the different strains (Morel et al. 2001; Becanovic et al. 2004) . Definition of subcongenic strains from the C15R4 strain will be performed to further reduce the size of the congenic fragment contributing to relative disease protection. Positional cloning will then be needed to define the exact genes responsible for the EAE-regulating effect of Eae19. Successful positional cloning through the definition of smaller and smaller congenic fragments has recently been demonstrated in rat experimental arthritis (Olofsson et al. 2003) .
A possible problem with gene mapping in congenic strains is the presence of contaminating fragments of DNA from the donor strain, contributing to differences in the disease phenotype between the congenic strains and the parental strains that wrongly would be interpreted as genetically localized to the congenic fragment. The speed congenic strategy applied in the present study is a way to improve the control of contaminating argues against any significant contributions from contaminating ACI DNA fragments outside Eae19, since those strains are expected to share possible contaminatrevealed that Eae19 is syntenic to human 13q22.1-q31.2 ing fragments with the C15R3b and the C15R4 strains. (Table 1) .
Another issue in the analysis of EAE QTL is the stability of the models and the observed genetic effects. In the DISCUSSION present study, there were clear differences in the six different experiments regarding disease severity in the The definition of Eae19 in two different strain combinaparental DA rat strain (Figure 3 , a and b) as well as a tions (DA ϫ ACI and DA ϫ PVG.AV1) strengthens the variable difference between the full-length C15 and the importance of this locus. Further mapping of genes may DA strain. Differences in the disease expression in paalso be facilitated by comparisons of genetic polymorrental/control strains are possible to minimize by phisms among the three different strains, especially applying strict protocols for immunization and environsince the low polymorphism rate between the DA and mental monitoring, but in practice it is very difficult to the ACI strain may decrease substantially the number obtain completely stable conditions in EAE. It may also of relevant genetic polymorphisms. However, at this stage it is impossible to rule out that Eae19 is composed be argued that repeating experiments with different QTL cluster 12 (Stoll et al. 2000) , and gastric cancer Coraddu, F., 2001 A genome screen for multiple sclerosis in Sardinsusceptibility QTL 1 (Ushijima et al. 2000) . Aia4 may be ian multiplex families. Eur. J. Hum. Genet. 9: 621-626.
the most interesting of these QTL, since we previously
